Literature DB >> 15749873

The role of intercellular adhesion molecule-1/LFA-1 interactions in the generation of tumor-specific CD8+ T cell responses.

S Rhiannon Jenkinson1, Neil A Williams, David J Morgan.   

Abstract

The activation of naive CD4+ T cells requires both TCR engagement and a second costimulatory signal mediated by the interaction of CD28 with CD80/CD86 expressed on professional APC. However, the situation for naive CD8+ T cells is less clear. Although evidence indicates that induction of CD8+ T cell responses is also dependent on professional APC, the ability of some tumors, which do not express CD80/CD86, to induce CTL suggests that other pathways of costimulation exist for the activation of CD8+ T cells. We examined the ability of tumor cells expressing different levels of a tumor-specific Ag to directly prime CD8+ T cells. We demonstrate that CD8+ T cells are directly activated by tumor cells in a CD80/CD86-CD28 independent manner. In this system, costimulation requires ICAM-1/LFA-1 interaction. This results in the generation of CTL capable of inhibiting tumor growth in vivo, and maintaining long-term survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749873     DOI: 10.4049/jimmunol.174.6.3401

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells.

Authors:  Yang Wang; Dan Li; Roza Nurieva; Justin Yang; Mehmet Sen; Roberto Carreño; Sijie Lu; Bradley W McIntyre; Jeffrey J Molldrem; Glen B Legge; Qing Ma
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

Review 2.  Molecular alterations in glioblastoma: potential targets for immunotherapy.

Authors:  Azizul Haque; Naren L Banik; Swapan K Ray
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

3.  Differences in sensitivity to tumor-specific CTLs between primary and metastatic esophageal cancer cell lines derived from the same patient.

Authors:  Yoshinobu Ichiki; Takeshi Hanagiri; Mitsuhiro Takenoyama; Tetsuro Baba; Yoshika Nagata; Makiko Mizukami; Tetsuya So; Masakazu Sugaya; Manabu Yasuda; Hidetaka Uramoro; Kosei Yasumoto
Journal:  Surg Today       Date:  2012-01-12       Impact factor: 2.549

Review 4.  How patients with an intact immune system develop head and neck cancer.

Authors:  Sarah Greene; Priya Patel; Clint T Allen
Journal:  Oral Oncol       Date:  2019-03-18       Impact factor: 5.337

5.  Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization.

Authors:  Melissa Frick; Pierre Mouchacca; Grégory Verdeil; Yannick Hamon; Cyrille Billaudeau; Michel Buferne; Mathieu Fallet; Nathalie Auphan-Anezin; Anne-Marie Schmitt-Verhulst; Claude Boyer
Journal:  Immunology       Date:  2016-11-02       Impact factor: 7.397

6.  ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells.

Authors:  Ofer Regev; Marina Kizner; Francesco Roncato; Maya Dadiani; Massimo Saini; Francesc Castro-Giner; Olga Yajuk; Stav Kozlovski; Nehora Levi; Yoseph Addadi; Ofra Golani; Shifra Ben-Dor; Zvi Granot; Nicola Aceto; Ronen Alon
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

7.  Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo.

Authors:  Maryam Ahmadi; David C Emery; David J Morgan
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

8.  Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.

Authors:  Ryo Ueda; Gary Kohanbash; Kotaro Sasaki; Mitsugu Fujita; Xinmei Zhu; Edward R Kastenhuber; Heather A McDonald; Douglas M Potter; Ronald L Hamilton; Michael T Lotze; Saleem A Khan; Robert W Sobol; Hideho Okada
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-11       Impact factor: 11.205

9.  The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.

Authors:  Beatrice Ondondo; Lee Faulkner; Neil A Williams; Andrew J Morgan; David J Morgan
Journal:  Cancer Med       Date:  2015-02-02       Impact factor: 4.452

10.  Biomedical insights into cell adhesion and migration-from a viewpoint of central nervous system tumor immunology.

Authors:  Mitsugu Fujita; Takaaki Matsui; Akihiko Ito
Journal:  Front Cell Dev Biol       Date:  2015-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.